Anesthesia remains a dynamic industry as leaders explore new methods of opioid-free pain management and expand into new care settings. Christina Menor, MD, president-elect of the California Society of ...
Many patients face delays in receiving support due to gaps between primary and specialized care. Collaborative programs ...
Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.
MyChesCo on MSN4d
FDA Approves First-in-Class Non-Opioid Pain Drug JournavxThe U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking ...
Learn more about whether Option Care Health, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Daily Voice Adams County PA on MSN7d
Non-Opioid Pain Medication Journavx Gets FDA ApprovalThe Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
A new study has found that adults with newly diagnosed sciatica who received chiropractic spinal manipulation (CSM) were significantly less likely to experience opioid-related adverse drug events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback